DHR Technical Analysis
As of date:5/11/2021
DHR stock price:257.91
DHR 50 DMA:234.14
DHR 200 DMA:224.64
DHR MACD (200-50):-9.50
DHR RSI:71.63
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)71.63
Extremely
Oversold

Also see:
DHR Market Cap History
DHR Shares Outstanding History
DHR YTD Return

Try ChartSweeps today
Quotes delayed 20 minutes
Get Free SEC filing alerts for DHR:
DHR SEC Filing Email Alerts ServiceExternal link

Cavco Industries (CVCO) Shares Cross Below 200 DMA
58 minutes ago


Fossil Group Breaks Below 200-Day Moving Average - Notable for FOSL
1 hour, 7 minutes ago


Cornerstone Total Return Fund Shares Cross Below 200 DMA
1 hour, 13 minutes ago


TMX Crosses Below Key Moving Average Level
1 hour, 27 minutes ago


Notable Two Hundred Day Moving Average Cross - IGI
1 hour, 33 minutes ago


Notable Two Hundred Day Moving Average Cross - AWK
1 hour, 37 minutes ago


Notable Two Hundred Day Moving Average Cross - CMG
1 hour, 39 minutes ago


FFC Makes Notable Cross Below Critical Moving Average
1 hour, 40 minutes ago


SONY Makes Notable Cross Below Critical Moving Average
1 hour, 43 minutes ago


Japan Smaller Capitalization Fund (JOF) Shares Cross Below 200 DMA
1 hour, 45 minutes ago


Ritchie Bros Auctioneers (RBA) Shares Cross Below 200 DMA
1 hour, 45 minutes ago


Notable Two Hundred Day Moving Average Cross - PFFD
1 hour, 46 minutes ago


CrediCorp (BAP) Shares Cross Above 200 DMA
1 hour, 47 minutes ago


PRGO Makes Bullish Cross Above Critical Moving Average
1 hour, 47 minutes ago


iShares National Muni Bond (MUB) Shares Cross Below 200 DMA
1 hour, 47 minutes ago


More Technical Analysis News

DHR Technical AnalysisDHR RSI
Danaher designs, manufactures and markets medical, industrial and commercial products and services. Co.'s segments are: Life Sciences, which provides instruments to study genes, proteins, metabolites and cells, in order to understand the causes of disease, identify therapies, and test drugs and vaccines; Diagnostics, which provides analytical instruments, reagents, consumables, software and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions; and Environmental and Applied Solutions, which provides products and services to protect resources and global food and water supplies.

When researching a stock like Danaher, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from DHR Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for DHR stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
DHR DMADHR MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Danaher (DHR) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

DVA Technical Analysis
EW Technical Analysis
GILD Technical Analysis
HCA Technical Analysis
HOLX Technical Analysis
HSIC Technical Analysis
IDXX Technical Analysis
ILMN Technical Analysis
INCY Technical Analysis
IQV Technical Analysis
More Healthcare companies »

 

DHR Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2021, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.